Abstract
The carbonic anhydrase (CA) protein family consists of twelve active isozymes in humans and thirteen in most other mammals. The most recently discovered members of this family include cytosolic CA XIII and membrane-bound CAs XIV and XV. In this article we will review the characterization and inhibition profiles of these isozymes. CA XIII is expressed in the kidney as well as in the gastrointestinal and reproductive tracts, and therefore it may have a role in various physiological processes. The inhibition studies with CA XIII have shown that this isozyme can be inhibited efficiently with some sulfonamide inhibitors, while it is resistant to inhibition with chloride and bicarbonate ions. CA XIV is a membrane-bound enzyme that is expressed in numerous organs such as the brain, kidney, eye, liver and epididymis, where it has a role in the regulation of acid-base balance. The inhibitory properties of CA XIV have been studied, but no specific inhibitors have been found for this isozyme. The membrane-bound CA XV is an exceptional member of this protein family, because it is expressed in numerous species but absent in humans and chimpanzees. A detailed biochemical characterization of this isozyme is under way in our laboratories.
Keywords: Carbonic anhydrase XIII, carbonic anhydrase XIV, carbonic anhydrase XV, characterization, inhibition
Current Topics in Medicinal Chemistry
Title: Characterization and Inhibition of the Recently Discovered Carbonic Anhydrase Isoforms CA XIII, XIV and XV
Volume: 7 Issue: 9
Author(s): Mika Hilvo, Claudiu T. Supuran and Seppo Parkkila
Affiliation:
Keywords: Carbonic anhydrase XIII, carbonic anhydrase XIV, carbonic anhydrase XV, characterization, inhibition
Abstract: The carbonic anhydrase (CA) protein family consists of twelve active isozymes in humans and thirteen in most other mammals. The most recently discovered members of this family include cytosolic CA XIII and membrane-bound CAs XIV and XV. In this article we will review the characterization and inhibition profiles of these isozymes. CA XIII is expressed in the kidney as well as in the gastrointestinal and reproductive tracts, and therefore it may have a role in various physiological processes. The inhibition studies with CA XIII have shown that this isozyme can be inhibited efficiently with some sulfonamide inhibitors, while it is resistant to inhibition with chloride and bicarbonate ions. CA XIV is a membrane-bound enzyme that is expressed in numerous organs such as the brain, kidney, eye, liver and epididymis, where it has a role in the regulation of acid-base balance. The inhibitory properties of CA XIV have been studied, but no specific inhibitors have been found for this isozyme. The membrane-bound CA XV is an exceptional member of this protein family, because it is expressed in numerous species but absent in humans and chimpanzees. A detailed biochemical characterization of this isozyme is under way in our laboratories.
Export Options
About this article
Cite this article as:
Hilvo Mika, Supuran T. Claudiu and Parkkila Seppo, Characterization and Inhibition of the Recently Discovered Carbonic Anhydrase Isoforms CA XIII, XIV and XV, Current Topics in Medicinal Chemistry 2007; 7 (9) . https://dx.doi.org/10.2174/156802607780636672
DOI https://dx.doi.org/10.2174/156802607780636672 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Current Drug Targets - Infectious Disorders Antineoplastic Activities, Apoptotic Mechanism of Action and Structural Properties of a Novel Silver(I) Chelate
Current Medicinal Chemistry Gene Therapy and Cell Reprogramming For the Aging Brain: Achievements and Promise
Current Gene Therapy Non-Invasive Imaging of Complicated Osteomyelitis: The Added Value of Scintigraphic Techniques
Current Radiopharmaceuticals Computational and Synthetic Biology Approaches for the Biosynthesis of Antiviral and Anticancer Terpenoids from <i>Bacillus subtilis</i>
Medicinal Chemistry Current Trends in the Chemotherapy of Colorectal Cancer
Current Medicinal Chemistry E6 and E7 Oncoproteins: Potential Targets of Cervical Cancer
Current Medicinal Chemistry Design and Synthesis of 3,4-diarylpyrrole Analogues as Potent Topoisomerase Inhibitors
Medicinal Chemistry Surgical Treatment in FIGO Stage I Cervical Cancer: Evolution of Concepts
Current Women`s Health Reviews Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy
Current Pharmaceutical Design The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases
Current Pharmaceutical Design Recent Advances in Physical Delivery Enhancement of Topical Drugs
Current Pharmaceutical Design Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Cornea: Window to Ocular Immunology
Current Immunology Reviews (Discontinued) Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Current Pharmaceutical Design Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy
Current Drug Metabolism Transmission and Immunopathogenesis of FIV in Cats as a Model for HIV
Current HIV Research Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry HR MAS MR Spectroscopy in Metabolic Characterization of Cancer
Current Topics in Medicinal Chemistry